SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
December 23, 2004
Date of Report
(Date of earliest event reported)
VERTRUE INCORPORATED
(Exact name of registrant as specified in its charter)
DELAWARE 0-21527 06-1276882
------------------------- ----------------------- ------------------
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
680 Washington Blvd
Stamford, Connecticut 06901
-----------------------------
(Address of principal executive offices,
including zip code)
(203) 324-7635
----------------------------------------------------
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2 below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
VERTRUE INCORPORATED
Item 8.01. Other Events.
On December 23, 2004, Vertrue Incorporated (the "Company") announced it has
entered into an agreement to acquire certain of the assets of My Choice Medical
Holdings, Inc., a privately held advertising and practice management company
serving cosmetic surgeons throughout the United States. Vertrue has agreed to
pay $33 million in cash at closing. In addition, contingent payments may be paid
if certain performance targets, including increasing levels of revenue and
earnings, are achieved over the next three calendar years. The contingent
payments will not exceed $56 million. The transaction is subject to customary
closing conditions and is expected to be completed before January 31, 2005. A
copy of the press release is attached as exhibit 99.1.
Item 9.01. Financial Statements, Pro Forma Financial Statements and Exhibits.
(c) Exhibits:
99.1 Press release dated December 23, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
VERTRUE INCORPORATED
(Registrant)
Date: December 23, 2004
By: /s/ Gary A. Johnson
--------------------------------
NAME: Gary A. Johnson
TITLE: President and Chief
Executive Officer
INDEX TO EXHIBITS
No. Description
---- -----------
99.1 Press release dated December 23, 2004.